BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glasner DR, Puerta-Guardo H, Beatty PR, Harris E. The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis. Annu Rev Virol 2018;5:227-53. [PMID: 30044715 DOI: 10.1146/annurev-virology-101416-041848] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Lytton SD, Nematollahi G, van Tong H, Xuan Anh C, Hung HV, Hoan NX, Diez G, Schumacher T, Landt O, Melchior W, Fuchs D, Toan NL, Velavan TP, Song LH. Predominant secondary dengue infection among Vietnamese adults mostly without warning signs and severe disease. Int J Infect Dis 2020;100:316-23. [PMID: 32896661 DOI: 10.1016/j.ijid.2020.08.082] [Reference Citation Analysis]
2 Wilken L, Rimmelzwaan GF. Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design? Pathogens 2020;9:E470. [PMID: 32549226 DOI: 10.3390/pathogens9060470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current Understanding of the Pathogenesis of Dengue Virus Infection. Curr Microbiol. 2021;78:17-32. [PMID: 33231723 DOI: 10.1007/s00284-020-02284-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ratanakomol T, Roytrakul S, Wikan N, Smith DR. Oroxylin A shows limited antiviral activity towards dengue virus. BMC Res Notes 2022;15:154. [PMID: 35509105 DOI: 10.1186/s13104-022-06040-0] [Reference Citation Analysis]
5 Puerta-Guardo H, Glasner DR, Espinosa DA, Biering SB, Patana M, Ratnasiri K, Wang C, Beatty PR, Harris E. Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism. Cell Rep 2019;26:1598-1613.e8. [PMID: 30726741 DOI: 10.1016/j.celrep.2019.01.036] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 46.0] [Reference Citation Analysis]
6 Vuong NL, Quyen NTH, Tien NTH, Tuan NM, Kien DTH, Lam PK, Tam DTH, Van Ngoc T, Yacoub S, Jaenisch T, Geskus RB, Simmons CP, Wills BA. Higher Plasma Viremia in the Febrile Phase Is Associated With Adverse Dengue Outcomes Irrespective of Infecting Serotype or Host Immune Status: An Analysis of 5642 Vietnamese Cases. Clin Infect Dis 2021;72:e1074-83. [PMID: 33340040 DOI: 10.1093/cid/ciaa1840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shoushtari M, Mafakher L, Rahmati S, Salehi-vaziri M, Arashkia A, Roohvand F, Teimoori-toolabi L, Azadmanesh K. Designing vaccine candidates against dengue virus by in silico studies on structural and nonstructural domains. Molecular and Cellular Probes 2022. [DOI: 10.1016/j.mcp.2022.101818] [Reference Citation Analysis]
8 Syzdykova LR, Binke S, Keyer VV, Shevtsov AB, Zaripov MM, Zhylkibayev AA, Ramanculov EM, Shustov AV. Fluorescent tagging the NS1 protein in yellow fever virus: Replication-capable viruses which produce the secretory GFP-NS1 fusion protein. Virus Res 2021;294:198291. [PMID: 33388393 DOI: 10.1016/j.virusres.2020.198291] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Caraballo GI, Rosales R, Viettri M, Castillo JM, Cruz R, Ding S, Greenberg HB, Ludert JE. The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells. J Virol 2022;:e0070422. [PMID: 35652656 DOI: 10.1128/jvi.00704-22] [Reference Citation Analysis]
10 Wang C, Puerta-Guardo H, Biering SB, Glasner DR, Tran EB, Patana M, Gomberg TA, Malvar C, Lo NTN, Espinosa DA, Harris E. Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutation. PLoS Pathog 2019;15:e1007938. [PMID: 31356638 DOI: 10.1371/journal.ppat.1007938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
11 Ramanathan HN, Zhang S, Douam F, Mar KB, Chang J, Yang PL, Schoggins JW, Ploss A, Lindenbach BD. A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating. mBio 2020;11:e00467-20. [PMID: 32291299 DOI: 10.1128/mBio.00467-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
12 Puerta-Guardo H, Tabata T, Petitt M, Dimitrova M, Glasner DR, Pereira L, Harris E. Zika Virus Nonstructural Protein 1 Disrupts Glycosaminoglycans and Causes Permeability in Developing Human Placentas. J Infect Dis 2020;221:313-24. [PMID: 31250000 DOI: 10.1093/infdis/jiz331] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
13 Rojas A, Cardozo F, Cantero C, Stittleburg V, López S, Bernal C, Gimenez Acosta FE, Mendoza L, Pinsky BA, Arévalo de Guillén I, Páez M, Waggoner J. Characterization of dengue cases among patients with an acute illness, Central Department, Paraguay. PeerJ 2019;7:e7852. [PMID: 31616598 DOI: 10.7717/peerj.7852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Chao CH, Wu WC, Lai YC, Tsai PJ, Perng GC, Lin YS, Yeh TM. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog 2019;15:e1007625. [PMID: 31009511 DOI: 10.1371/journal.ppat.1007625] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
15 Sinigaglia A, Peta E, Riccetti S, Barzon L. New avenues for therapeutic discovery against West Nile virus. Expert Opinion on Drug Discovery 2020;15:333-48. [DOI: 10.1080/17460441.2020.1714586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Sharma M, Glasner DR, Watkins H, Puerta-Guardo H, Kassa Y, Egan MA, Dean H, Harris E. Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate. J Infect Dis 2020;221:867-77. [PMID: 30783676 DOI: 10.1093/infdis/jiz081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
17 Pinto PBA, Assis ML, Vallochi AL, Pacheco AR, Lima LM, Quaresma KRL, Pereira BAS, Costa SM, Alves AMB. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification. Front Immunol 2019;10:1522. [PMID: 31333657 DOI: 10.3389/fimmu.2019.01522] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Jia H, Zhong Y, Peng C, Gong P. Crystal Structures of Flavivirus NS5 Guanylyltransferase Reveal a GMP-Arginine Adduct. J Virol 2022;:e0041822. [PMID: 35758665 DOI: 10.1128/jvi.00418-22] [Reference Citation Analysis]
19 Ci Y, Shi L. Compartmentalized replication organelle of flavivirus at the ER and the factors involved. Cell Mol Life Sci 2021;78:4939-54. [PMID: 33846827 DOI: 10.1007/s00018-021-03834-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Allonso D. Production of Properly Folded NS1 Protein in Bacterial Cells. Methods Mol Biol 2022;2409:31-8. [PMID: 34709633 DOI: 10.1007/978-1-0716-1879-0_3] [Reference Citation Analysis]
21 Dey D, Poudyal S, Rehman A, Hasan SS. Structural and biochemical insights into flavivirus proteins. Virus Res 2021;296:198343. [PMID: 33607183 DOI: 10.1016/j.virusres.2021.198343] [Reference Citation Analysis]
22 Cai W, Pan Y, Cheng A, Wang M, Yin Z, Jia R. Regulatory Role of Host MicroRNAs in Flaviviruses Infection. Front Microbiol 2022;13:869441. [DOI: 10.3389/fmicb.2022.869441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 de Lima Menezes G, Vogel Saivish M, Lacerda Nogueira M, Alves da Silva R. Virtual screening of small natural compounds against NS1 protein of DENV, YFV and ZIKV. J Biomol Struct Dyn 2022;:1-11. [PMID: 35188085 DOI: 10.1080/07391102.2022.2042390] [Reference Citation Analysis]
24 Paz-Bailey G, Adams L, Wong JM, Poehling KA, Chen WH, McNally V, Atmar RL, Waterman SH. Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recomm Rep 2021;70:1-16. [PMID: 34978547 DOI: 10.15585/mmwr.rr7006a1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ooi JSG, Lok SM. How NS1 Antibodies Prevent Severe Flavivirus Disease. Trends Biochem Sci 2021;46:519-21. [PMID: 33895084 DOI: 10.1016/j.tibs.2021.03.005] [Reference Citation Analysis]
26 van Leur SW, Heunis T, Munnur D, Sanyal S. Pathogenesis and virulence of flavivirus infections. Virulence 2021;12:2814-38. [PMID: 34696709 DOI: 10.1080/21505594.2021.1996059] [Reference Citation Analysis]
27 Zhang S, Wang X, He Y, Hu T, Guo J, Wang M, Jia R, Zhu D, Liu M, Zhao X, Yang Q, Wu Y, Zhang S, Huang J, Mao S, Ou X, Gao Q, Sun D, Liu Y, Zhang L, Chen S, Cheng A. N130, N175 and N207 are N-linked glycosylation sites of duck Tembusu virus NS1 that are important for viral multiplication, viremia and virulence in ducklings. Vet Microbiol 2021;261:109215. [PMID: 34455356 DOI: 10.1016/j.vetmic.2021.109215] [Reference Citation Analysis]
28 Płaszczyca A, Scaturro P, Neufeldt CJ, Cortese M, Cerikan B, Ferla S, Brancale A, Pichlmair A, Bartenschlager R. A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle. PLoS Pathog 2019;15:e1007736. [PMID: 31071189 DOI: 10.1371/journal.ppat.1007736] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
29 Gubler DJ, Halstead SB. Is Dengvaxia a useful vaccine for dengue endemic areas? BMJ 2019;367:l5710. [PMID: 31582375 DOI: 10.1136/bmj.l5710] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
30 Teo A, Chua CLL, Chia PY, Yeo TW. Insights into potential causes of vascular hyperpermeability in dengue. PLoS Pathog 2021;17:e1010065. [PMID: 34882753 DOI: 10.1371/journal.ppat.1010065] [Reference Citation Analysis]
31 Kapuganti SK, Kumar P, Giri R. Structural dynamics of Zika virus NS1 via a reductionist approach reveal the disordered nature of its β-roll domain in isolation. Virology 2022;573:72-83. [PMID: 35724498 DOI: 10.1016/j.virol.2022.06.005] [Reference Citation Analysis]
32 De Pasquale V, Quiccione MS, Tafuri S, Avallone L, Pavone LM. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2. Int J Mol Sci 2021;22:6574. [PMID: 34207476 DOI: 10.3390/ijms22126574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Idris F, Ting DHR, Alonso S. An update on dengue vaccine development, challenges, and future perspectives. Expert Opin Drug Discov 2021;16:47-58. [PMID: 32838577 DOI: 10.1080/17460441.2020.1811675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Gomes de Sousa FT, Biering SB, Patel TS, Blanc SF, Camelini CM, Venzke D, Nunes R, Romano CM, Beatty PR, Sabino EC, Harris E. Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis. Antiviral Research 2022. [DOI: 10.1016/j.antiviral.2022.105330] [Reference Citation Analysis]
35 Quirino-Teixeira AC, Rozini SV, Barbosa-Lima G, Coelho DR, Carneiro PH, Mohana-Borges R, Bozza PT, Hottz ED. Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1. Blood Adv 2020;4:2018-31. [PMID: 32396616 DOI: 10.1182/bloodadvances.2019001169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
36 Zevini A, Ferrari M, Olagnier D, Hiscott J. Dengue virus infection and Nrf2 regulation of oxidative stress. Current Opinion in Virology 2020;43:35-40. [DOI: 10.1016/j.coviro.2020.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 Hsieh SC, Tsai WY, Tsai JJ, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections. J Virol 2021;95:e0061921. [PMID: 34232731 DOI: 10.1128/JVI.00619-21] [Reference Citation Analysis]
38 Biering SB, de Sousa FTG, Tjang LV, Pahmeier F, Ruan R, Blanc SF, Patel TS, Worthington CM, Glasner DR, Castillo-Rojas B, Servellita V, Lo NTN, Wong MP, Warnes CM, Sandoval DR, Clausen TM, Santos YA, Ortega V, Aguilar HC, Esko JD, Chui CY, Pak JE, Beatty PR, Harris E. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling. bioRxiv 2021:2021. [PMID: 34931188 DOI: 10.1101/2021.12.10.472112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Byrne AB, Talarico LB. Role of the complement system in antibody-dependent enhancement of flavivirus infections. Int J Infect Dis 2021;103:404-11. [PMID: 33352325 DOI: 10.1016/j.ijid.2020.12.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
40 Lebeau G, Lagrave A, Ogire E, Grondin L, Seriacaroupin S, Moutoussamy C, Mavingui P, Hoarau JJ, Roche M, Krejbich-Trotot P, Desprès P, Viranaicken W. Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine. Vaccines (Basel) 2021;9:946. [PMID: 34579183 DOI: 10.3390/vaccines9090946] [Reference Citation Analysis]
41 Halstead SB. Travelling arboviruses: A historical perspective. Travel Medicine and Infectious Disease 2019;31:101471. [DOI: 10.1016/j.tmaid.2019.101471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
42 Stiasny K, Leitner A, Holzmann H, Heinz FX. Dynamics and Extent of Non-Structural Protein 1-Antibody Responses in Tick-Borne Encephalitis Vaccination Breakthroughs and Unvaccinated Patients. Viruses 2021;13:1007. [PMID: 34072119 DOI: 10.3390/v13061007] [Reference Citation Analysis]
43 Puerta-guardo H, Biering SB, de Sousa FTG, Shu J, Glasner DR, Li J, Blanc SF, Beatty PR, Harris E. Flavivirus NS1 Triggers Tissue-Specific Disassembly of Intercellular Junctions Leading to Barrier Dysfunction and Vascular Leak in a GSK-3β-Dependent Manner. Pathogens 2022;11:615. [DOI: 10.3390/pathogens11060615] [Reference Citation Analysis]
44 Katzelnick LC, Bos S, Harris E. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus. Curr Opin Virol 2020;43:59-70. [PMID: 32979816 DOI: 10.1016/j.coviro.2020.08.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
45 Montes-Grajales D, Puerta-Guardo H, Espinosa DA, Harris E, Caicedo-Torres W, Olivero-Verbel J, Martínez-Romero E. In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection. Antiviral Res 2020;173:104668. [PMID: 31786251 DOI: 10.1016/j.antiviral.2019.104668] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Halstead SB, Dans LF. Dengue infection and advances in dengue vaccines for children. Lancet Child Adolesc Health 2019;3:734-41. [PMID: 31378686 DOI: 10.1016/S2352-4642(19)30205-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
47 Lu ZY, Cheng MH, Yu CY, Lin YS, Yeh TM, Chen CL, Chen CC, Wan SW, Chang CP. Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1. Int J Mol Sci 2020;21:E9702. [PMID: 33352639 DOI: 10.3390/ijms21249702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Zhang M, Sun J, Li M, Jin X. Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice. Mol Ther Methods Clin Dev 2020;18:702-12. [PMID: 32913878 DOI: 10.1016/j.omtm.2020.07.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
49 Ngwe Tun MM, Nguyen TTT, Ando T, Dumre SP, Soe AM, Buerano CC, Nguyen MT, Le NTN, Pham VQ, Nguyen TH, Le TQM, Morita K, Hasebe F. Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017. Am J Trop Med Hyg 2020;102:1217-25. [PMID: 32189614 DOI: 10.4269/ajtmh.19-0607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Sharp TM, Anderson KB, Katzelnick LC, Clapham H, Johansson MA, Morrison AC, Harris E, Paz-Bailey G, Waterman SH. Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluation. Lancet Infect Dis 2021:S1473-3099(20)30871-9. [PMID: 34265259 DOI: 10.1016/S1473-3099(20)30871-9] [Reference Citation Analysis]
51 Alves AMB, Costa SM, Pinto PBA. Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge? Front Med Technol 2021;3:640964. [PMID: 35047911 DOI: 10.3389/fmedt.2021.640964] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kao YS, Yu CY, Huang HJ, Tien SM, Wang WY, Yang M, Anderson R, Yeh TM, Lin YS, Wan SW. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection. J Immunol 2019;203:1909-17. [PMID: 31451673 DOI: 10.4049/jimmunol.1900136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
53 Ci Y, Liu ZY, Zhang NN, Niu Y, Yang Y, Xu C, Yang W, Qin CF, Shi L. Zika NS1-induced ER remodeling is essential for viral replication. J Cell Biol 2020;219:e201903062. [PMID: 31868887 DOI: 10.1083/jcb.201903062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
54 Pan YH, Liao MY, Chien YW, Ho TS, Ko HY, Yang CR, Chang SF, Yu CY, Lin SY, Shih PW, Shu PY, Chao DY, Pan CY, Chen HM, Perng GC, Ku CC, King CC. Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country. PLoS Negl Trop Dis 2021;15:e0009312. [PMID: 33793562 DOI: 10.1371/journal.pntd.0009312] [Reference Citation Analysis]
55 Halstead SB, Katzelnick L. COVID-19 Vaccines: Should We Fear ADE? J Infect Dis 2020;222:1946-50. [PMID: 32785649 DOI: 10.1093/infdis/jiaa518] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
56 Rojas A, Natrajan MS, Weber J, Cardozo F, Cantero C, Ananta JS, Kost J, Tang M, López S, Bernal C, Guillén Y, Mendoza L, Páez M, Pinsky BA, Waggoner JJ. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing. Am J Trop Med Hyg 2021:tpmd201449. [PMID: 33782214 DOI: 10.4269/ajtmh.20-1449] [Reference Citation Analysis]
57 De S, Aamna B, Sahu R, Parida S, Behera SK, Dan AK. Seeking heterocyclic scaffolds as antivirals against dengue virus. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114576] [Reference Citation Analysis]
58 Huang H, Yang M, Chen H, Wang S, Chang C, Ho T, Kao Y, Tien S, Lin H, Chang P, Lai Y, Hsiao Y, Liu Y, Chao C, Anderson R, Yeh T, Lin Y, Wan S. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.070] [Reference Citation Analysis]
59 Ferrari M, Zevini A, Palermo E, Muscolini M, Alexandridi M, Etna MP, Coccia EM, Fernandez-Sesma A, Coyne C, Zhang DD, Marques ETA, Olagnier D, Hiscott J. Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication. J Virol 2020;94:e01551-20. [PMID: 32999020 DOI: 10.1128/JVI.01551-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
60 Suputtamongkol Y, Avirutnan P, Mairiang D, Angkasekwinai N, Niwattayakul K, Yamasmith E, Saleh-Arong FA, Songjaeng A, Prommool T, Tangthawornchaikul N, Puttikhunt C, Hunnangkul S, Komoltri C, Thammapalo S, Malasit P. Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial. Clin Infect Dis 2021;72:e586-93. [PMID: 33462580 DOI: 10.1093/cid/ciaa1332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
61 Allonso D, Pereira IB, Alves AM, Kurtenbach E, Mohana-Borges R. Expression of soluble, glycosylated and correctly folded dengue virus NS1 protein in Pichia pastoris. Protein Expr Purif 2019;162:9-17. [PMID: 31077812 DOI: 10.1016/j.pep.2019.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 O'Donnell KL, Espinosa DA, Puerta-Guardo H, Biering SB, Warnes CM, Schiltz J, Nilles ML, Li J, Harris E, Bradley DS. Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge. Antiviral Res 2020;183:104923. [PMID: 32979401 DOI: 10.1016/j.antiviral.2020.104923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Menezes GDL, Gonçalves RL, Lima RM, Pereira M, Moreli ML, da Silva RA. Mutation of critical residues reveals insights of yellow fever virus nonstructural protein 1 (NS1) stability and its formation. Journal of Biomolecular Structure and Dynamics 2020;38:5277-86. [DOI: 10.1080/07391102.2019.1695673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Li A, Xue M, Attia Z, Yu J, Lu M, Shan C, Liang X, Gao TZ, Shi PY, Peeples ME, Boyaka PN, Liu SL, Li J. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection. J Virol 2020;94:e00048-20. [PMID: 32554698 DOI: 10.1128/JVI.00048-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
65 Mapalagamage M, Handunnetti SM, Wickremasinghe AR, Premawansa G, Thillainathan S, Fernando T, Kanapathippillai K, De Silva AD, Premawansa S. High Levels of Serum Angiopoietin 2 and Angiopoietin 2/1 Ratio at the Critical Stage of Dengue Hemorrhagic Fever in Patients and Association with Clinical and Biochemical Parameters. J Clin Microbiol 2020;58:e00436-19. [PMID: 31941693 DOI: 10.1128/JCM.00436-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
66 Hou J, Ye W, Chen J. Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines. Front Immunol 2022;13:840104. [PMID: 35281026 DOI: 10.3389/fimmu.2022.840104] [Reference Citation Analysis]
67 Zhou D, Pei C, Liu Z, Yang K, Li Q, Chen H, Cao S, Song Y. Identification of a protective epitope in Japanese encephalitis virus NS1 protein. Antiviral Res 2020;182:104930. [PMID: 32898585 DOI: 10.1016/j.antiviral.2020.104930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]